COMMUNIQUÉS West-GlobeNewswire
-
Tevogen Complements Capital Access with Two-Year Extension to Loan Agreement
09/11/2026 -
Evaxion files amendment to registration statement related to 2025 EIB debt settlement agreement
09/11/2026 -
Novastra Therapeutics Reports Further Encouraging Clinical Data for Its Novel XIRT™/OAP Cancer Immune Therapy at SITC 2026
09/11/2026 -
Allogene Therapeutics Reports First Clinical Data from Phase 1 RESOLUTION Study of ALLO-329 in Autoimmune Disease
09/11/2026 -
Profound Medical to Participate in the Stifel 2026 Healthcare Conference
09/11/2026 -
Immuneering Appoints Accomplished Commercial Leader Grant Bogle to Board of Directors
09/11/2026 -
Cognition Therapeutics Invited to Participate in 2026 Jefferies Global Healthcare Conference
09/11/2026 -
BridgeBio to Participate in November and December Investor Conferences
09/11/2026 -
PharmAla Biotech Signs Supply and Data Agreement with Aalborg University Hospital for Danish Randomized Trial of MDMA-Assisted Treatment for Service-Related PTSD
09/11/2026 -
Cytokinetics Announces Additional Data Related to Aficamten Presented at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026
09/11/2026 -
Bicara Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
09/11/2026 -
Braveheart Bio to Participate in the Jefferies Global Healthcare Conference in London
09/11/2026 -
CervoMed Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
09/11/2026 -
Novo Nordisk A/S - share repurchase programme
09/11/2026 -
Foghorn Therapeutics Provides Third Quarter 2026 Financial and Corporate Update
09/11/2026 -
OrthoPediatrics Announces Full Commercial Launch of VerteGlide® Spinal Growth Guidance System
09/11/2026 -
NeurAxis Reports Record Third Quarter 2026 Financial Results Driven by 150% Year Over Year Revenue Growth
09/11/2026 -
Kamada Reports Record-High First Nine Months 2026 Financial Results; Increases 2026 Annual Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2027
09/11/2026 -
Immunocore to present at upcoming investor conferences
09/11/2026
Pages